mTOR regulates the expression of DNA damage response enzymes in long‐lived Snell dwarf, GHRKO, and PAPPA‐KO mice by Dominick, Graham et al.
mTOR regulates the expression of DNA damage response
enzymes in long-lived Snell dwarf, GHRKO, and PAPPA-KO mice
Graham Dominick,1 Jacqueline Bowman,1 Xinna Li,2
Richard A. Miller2,3 and Gonzalo G. Garcia2
1Department of Molecular, Cellular, and Developmental Biology, University of
Michigan College of Literature, Science and the Arts, Ann Arbor, MI, USA
2Department of Pathology, University of Michigan School of Medicine, Ann
Arbor, MI, USA
3University of Michigan Geriatrics Center, Ann Arbor, MI, USA
Summary
Studies of the mTOR pathway have prompted speculation that
diminished mTOR complex-1 (mTORC1) function may be involved
in controlling the aging process. Our previous studies have
shown diminished mTORC1 activity in tissues of three long-lived
mutant mice: Snell dwarf mice, growth hormone receptor gene
disrupted mice (GHRKO), and in this article, mice deficient in the
pregnancy-associated protein-A (PAPPA-KO). The ways in which
lower mTOR signals slow aging and age-related diseases are,
however, not well characterized. Here, we show that Snell,
GHKRO, and PAPPA-KO mice express high levels of two proteins
involved in DNA repair, O-6-methylguanine-DNA methyltrans-
ferase (MGMT) andN-myc downstream-regulatedgene 1 (NDRG1).
Furthermore, we report that loweringmTOR enhances MGMT and
NDRG1 protein expression via post-transcriptional mechanisms.
We show that the CCR4-NOT complex, a post-transcriptional
regulator of gene expression, is downstream of the mTORC1
pathway and may be responsible for the upregulation of MGMT
and NDRG1 in all three varieties of long-lived mice. Our data thus
suggest a novel link between DNA repair and mTOR signaling via
post-transcriptional regulation involving specific alteration in the
CCR4-NOT complex, whose modulation could control multiple
aspects of the aging process.
Key words: DNA repair; gene expression; IGF; molecular
biology of aging; signal transduction.
Abbreviations
DW Snell dwarf mice
GHRKO growth hormone receptor deletion mice
MGMT O-6-methylguanine-DNA methyltransferase
mTOR mammalian target of rapamycin
NDRG1 N-myc downstream-regulated gene 1
PAPPA-
KO or KO
pregnancy-associated protein-A deletion mice
Introduction
Several lines of evidence have implicated the mechanistic target of
rapamycin (mTOR) in the regulation of aging. In lower organisms, such
as Caenorhabditis elegans and Drosophila melanogaster, inactivation or
reduction of mTOR activity results in life extension (Sharp et al., 2013). In
addition, reduction of mTOR activity by rapamycin (Harrison et al., 2009)
or reduction in expression of mTOR kinase by hypomorphic mTOR alleles
(Selman et al., 2009; Lamming et al., 2012; Wu et al., 2013) can
increase mouse lifespan. mTOR is a serine/threonine kinase that forms
the catalytic core of at least two complexes, mTOR complex-1 (mTORC1)
and mTOR complex-2 (mTORC2). In vivo, the phosphorylation of
ribosomal protein S6 (pS6(235)) and initiation factor 4E-binding protein
(p4E-BP1(37)) are markers of mTORC1 activity. Phosphorylation of AKT at
Ser-473 (pAKT(473)), Ser-450 (pAKT(450)), and the N-myc downstream-
regulated gene (pNDRG(346)) are considered markers of mTORC2 activity.
We have recently studied the phosphorylation status of these substrates
in the Snell and GHRKO mice, two long-lived genetic models, and found
tissue-specific reduction in mTORC1 activity as well as alteration in
mTORC2 activity (Dominick et al., 2015). Interestingly, neither mTORC1
nor mTORC2 was altered in mice with liver-specific deletion of GHR,
mice in which lifespan is normal despite dramatically lower levels of
serum IGF-1 (Bartke, 2008; Dominick et al., 2015). The metallopro-
teinase PAPP-A is thought to act by regulating local IGF-1 action through
degradation of some IGF-1 binding proteins, particularly IGF-BP4
(Conover & Bale, 2007). PAPP-A deletion can extend both mean and
maximum lifespan by 20–40%, with a reduced incidence of sponta-
neous tumors, without modulation of serum levels of GH or IGF-1.
Effects of PAPPA-KO on mTORC1 and mTORC2 have not yet been
reported. The mechanistic links between GH/IGF-1 regulation and
prolongation of lifespan in these three varieties of mice are not well
understood.
O-6-methylguanine-DNA methyltransferase (MGMT) is an enzyme
involved in the direct reversal of DNA damage in vitro and postmitotic
cells in vivo by methylating agents used clinically for chemotherapy
(Iyama & Wilson, 2013; Jiang et al., 2014). It have been suggested that
MGMT may play a role in regulating mouse lifespan (Meira et al., 2014),
but it is not known whether long-lived mice, such as Snell, GHRKO, and
PAPPA-KO, have altered expression of MGMT. Higher expression of
NDRG1, a protein of unknown function, can promote MGMT protein
stability and activity in human glioma cells by mechanisms that include
protein interactions and preferential translation (Smalley et al., 2014;
Weiler et al., 2014). Therefore, understanding the signaling pathways
regulating MGMT and NDRG1 may provide insights into resistance to
DNA damage, chemotherapy, and the aging process. We hypothesized
that higher expression of MGMT and NDRG1 may be a common feature
shared by Snell, GHRKO, and PAPPA-KO mice, and that mTOR activity
could be a key upstream regulator of MGMT and NDRG1 expression.
Microarray analysis of the mRNA gene expression profiles of many
different models of slow-aging mice have not led to a consensus on
common pathway(s) central to the aging process, including mice whose
lifespan has been increased by mTOR reduction by drugs (Yu et al.,
2015) or dietary interventions (Swindell, 2008). However, it is plausible
that improved DNA repair may be one important common feature (Meira
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et al., 2014). Discrepancy between mRNA levels and protein expression
in many genes complicates interpretation of mRNA patterns in tissues of
slow-aging mice, and it is likely that gene regulation by post-
transcriptional mechanisms, including changes in mRNA stability
(Brewer, 2002; Lee & Gorospe, 2010), regulation by microRNAs (Bates
et al., 2010; Liang et al., 2011), and sequestration to P and ER bodiesmay
contribute to altered levels of DNA repair proteins in slow-aging mice.
The CCR4-NOT complex is a key regulator of mRNA stability,
microRNA function, and preferential translation, and functions as a
check point in the control of translation and protein degradation (Inada
& Makino, 2014; Shirai et al., 2014). The CCR4-NOT complex is
comprised of at least ten subunits, but there is limited information
about the function of individual components of the complex in
mammals. Recent reports using in vitro methods have helped to clarify
some functional roles of CNOT components (Laribee et al., 2015; Okada
et al., 2015; Rodriguez-Gil et al., 2016). Mice in which CNOT6 has been
deleted are viable but, with exception of some bone abnormalities, do
not have obvious changes in phenotype. However, CNOT3 heterozygous
mice (Morita et al., 2011) display some phenotypes reminiscent of Snell
(Bartke & Brown-Borg, 2004; Boylston et al., 2006), Ames dwarf
(Boylston et al., 2006), GHRKO (Brown-Borg & Bartke, 2012), and
PAPPA-KO mice (Hill et al., 2015), including higher insulin sensitivity,
improved glucose tolerance, and higher oxygen consumption. Here, we
present evidence suggesting that Snell, GHRKO, and PAPPA-KO mice
express high levels of NDRG1 and MGMT proteins that are under the
control of mTORC1 activity, and that this regulation involves post-
transcriptional mechanisms that may depend on alteration of the CCR4-
NOT complex.
Results
Multiple models of slow aging, including PAPPA-KO mice,
show lower mTORC1 activity
We have recently reported that Snell and GHRKO mice show reduced
mTORC1 activity in multiple tissues, accompanied by changes in both
fasting and food-induced mTORC2 activity (Dominick et al., 2015). To
see whether PAPPA-KO mice showed similar changes in mTORC1 and
mTORC2 activity, we measured phosphorylation of mTORC1 substrates
pS6(S235/236) [referred to as pS6 in figures and text], p4E-BP1(T37/46)
[termed p4E-BP1 in figures and text] and mTORC2 substrates pAKT(T450)
and pNDRG1(T346) [termed pNDRG1 in figures and text], either after 18 h
of fasting or after 18 h of fasting followed by 6 h of access to food
(Dominick et al., 2015). Figure 1A shows a representative Western blot
for liver, and Fig. 1B shows mean values from three independent
experiments using at least eight mice per group. We found no significant
sex effects (half of the mice were males) on any of the measures
reported in this article (data not shown). Table S1 shows parallel
experiments for muscle, heart, and kidney of PAPPA-KO mice for the
mTORC1 substrates, with estimates of fold induction as well as the
results of ANOVA testing significance of the effects of genotype
(G), nutritional conditions (fasting vs. feeding, N), and GxN interactions
(Int). We found that PAPPA-KO mice show lower levels of pS6 and
p4E-BP1, independent of nutritional status, in all four tissues tested
(Fig. 1 and Table S1, Supporting information). Two-factor ANOVA
confirmed the significant effect of the PAPP-A deletion (genotype
effects: WT > KO) and feeding (nutritional effects: fed > fasting),
without evidence for interaction. The result is similar to our findings
for Snell and GHRKO mice (Dominick et al., 2015). We found no
differences in the expression of total S6 or 4E-BP protein in any of the
groups (data not shown).
Results for mTORC2 substrates pAKT(450) and pNDRG are shown in
Fig. 1 for liver and are summarized in Table S2 (Supporting information)
for all four tissues. Consistent with Snell and GHRKO mice (Dominick
et al., 2015), fasted PAPPA-KO mice have higher mTORC2 activity, and
this activity decreases in response to feeding in PAPPA-KO but not in WT
control mice (Fig. 1). Statistical analysis using ANOVA confirmed that
feeding has significant interaction effects for pAKT(450) and pNDRG
(Fig. 1B and Table S2, Supporting information). The overall results
suggest that PAPPA-KO, Snell, and GHRKO mice share a common
regulatory mechanism for mTOR activity and signaling that includes
tissue-specific declines in mTORC1 activity and differential regulation of
mTORC2 activity.
Snell, GHRKO, and PAPPA-KO mice show higher NDRG1 and
MGMT protein expression, but no changes in NDRG1 or
MGMT mRNA expression
Using a rabbit monoclonal from Cell Signaling (D6C2), we noted an
increase in levels of total NDRG1 protein expression in liver of PAPPA-KO
mice (Fig. 1A). Higher NDRG1 expression has been associated with
enhanced DNA repair through increased MGMT protein stability/activity
(Weiler et al., 2014). We therefore measured NDRG1 and MGMT
protein expression in liver, skeletal muscle (upper leg), and kidney from
our three slow-aging mice models fed ad lib. The right panels of Fig. 2
show representative results from liver tissue in Snell (Fig. 2A), GHRKO
Fig. 1 mTORC activity in liver of PAPP-A mice. (A) Representative Western blots showing the phosphorylation of S6, 4E-BP1, AKT, and NDRG1 in liver samples from PAPPA-
KO (KO) and control littermates (WT) under fasting (Fasted) or fed (Fed) conditions. (B) Quantification of pS6, p4E-BP1, pAKT(450), and pNDRG1 phosphorylation as ratios to
the level of the corresponding protein. All bar graphs represent the mean  SEM from a total of eight mice (four females and four males) per group and are normalized with
respect to ratio of 1 in fasted WT for each protein. The asterisk (*) indicates statistical significance relative to the fasting WT from each group.
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(Fig. 2B), and PAPPA-KO (Fig. 2C). NDRG1 and MGMT protein expres-
sion was increased by 29 to 39 in each kind of slow-aging mouse.
To assess whether higher protein levels were the result of upregulation
of NDRG1 andMGMTmRNA transcripts, we performed qRT–PCR for both
genes in liver. In contrast to the protein data, there were no differences in
the levels of NDRG1 andMGMTmRNA in any of themousemodels (Fig. 2
right panels). We confirmed these results using three other differently
designed probes for MGMT and NDRG1 (data not shown). We also found
no differences in the GAPDH mRNA expression (Fig. S1, Supporting
information). This suggested that discrepancies between protein expres-
sion and mRNA levels might reflect differential post-transcriptional
regulation of MGMT and NDRG1 in slow-aging mice.
mTOR signaling regulates NDRG1 and MGMT protein
expression but not their mRNA expression
In some human cell lines, rapamycin (an mTOR inhibitor) can enhance
MGMT protein expression, and this increase is the result of preferential
translation of MGMT transcripts (Smalley et al., 2014). mTOR can also
regulate stress resistance by preferential translation of certain mRNAs
(Reiter et al., 2004), including ATF-4 (Ait et al., 2012). Hence, we
hypothesized that changes in mTOR function in Snell, GHRKO, and
PAPPA-KO mice could increase NDRG1 and MGMT via a post-
transcriptional pathway. To test this idea, we treated mouse fibroblasts
from a genetically heterogeneous stock of mice (Harrison et al., 2009)
with rapamycin for 48 h and analyzed the expression of NDRG1 and
MGMT using Western blots and qRT–PCR. The data (Fig. 3) show that
rapamycin enhances NDRG1 and MGMT protein expression, at a
concentration that impairs phosphorylation of the mTORC1 substrates
4E-BP1 and S6. Statistical analysis confirmed significant increases in
NDRG1 and MGMT protein in fibroblasts treated for 48 h with
rapamycin (Fig. 3A middle panel). Parallel mRNA analysis found no
differences in NDRG1 and MGMT mRNA expression (or in GAPDH
mRNA) in fibroblasts exposed to rapamycin for 24 or 72 h (not shown).
These results suggest that mTOR regulates fibroblast NDRG1 and MGMT
protein expression through a post-transcriptional mechanism. However,
extended rapamycin treatments can diminish expression and phospho-
rylation of some of the mTORC2 substrates [pAKT/AKT in Fig. 3A and
(Sarbassov et al., 2006; Lamming et al., 2012)], suggesting that lower
mTORC2 function may, in part, be responsible for some of the effects
we see in MGMT and NDRG1 expression. The overall results suggest that
mTOR plays a key role, but more work will be needed to determine the
specific role of each complex (mTORC1 and mTORC2) in these animals.
We also tested the in vivo effects of rapamycin on NDRG1 and MGMT
in liver. A single rapamycin injection increases NDRG1 and MGMT
protein expression in liver (Fig. 3B). Rapamycin leads to the expected
reduction in mTORC1 activity (indicated by pS6), and no apparent
changes in mTORC2 activity (as measured by phosphorylation of AKT450
and AKT473). Statistical analysis showed significant increases in NDRG1
and MGMT protein expression by rapamycin. Consistent with the
fibroblast experiments, there are no significant changes in NDRG1,
MGMT mRNA levels. The in vivo results suggest that mTOR can regulate
NDRG1 and MGMT expression through post-transcriptional mecha-
nisms, and that lower mTORC1 activity in Snell, GHRKO, and PAPPA-KO
mice may upregulate MGMT and NDRG1. However, Schreiber et al.
(2015) have suggested that rapamycin effects on mTORC2 signaling may
Fig. 2 Snell mice (DW), GHRKO, and
PAPP-A (KO) mice show higher NDRG1 and
MGMT protein expression but no
significant change in mRNA expression.
(A) Representative Western blots showing
NDRG1 and MGMT expression in Snell mice
(DW) from liver (left). Quantification in liver,
skeletal muscle, and kidney (middle panels)
is shown as mean  SEM from three
experiments, using a total of at least 12
mice (six females and six males) per group,
using normalization as described in Fig. 1.
The qRT–PCR CT dotplot values for NDRG1
and MGMT expression are shown in the
right panels. Each symbol represents an
individual mouse. Horizontal lines show
mean  SEM from a total of 16 mice (eight
females and eight males) per group. The
asterisk (*) indicates statistical significance
relative to the WT controls of each group.
(B) Results for GHRKO mice from at least 11
mice (six females and five males) per group
for protein expression (middle panels) and
for qRT–PCR using eight mice (four females
and four males) per group (right panels). (C)
Results for PAPPA-KO (KO) mice from at
least eight mice (four females and four
males) per group and qRT–PCR using at
least ten mice (five females and five males)
per group.
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be difficult to detect, and we cannot rule out the idea that mTORC2
could also play an important role in regulating MGMT and NDRG1
expression in the slow-aging mice.
Snell, GHRKO, and PAPPA-KO mice show similar alterations in
the expression of components of the CCR4-NOT complex
To see whether changes in components of the CCR4-NOT complex could
be involved in differential post-transcriptional regulation, we tested
expression of CNOT1, CNOT3, CNOT6, and CNOT6L in liver of Snell,
GHRKO, and PAPPA-KO mice. CNOT3 was selected because its decline
leads to some features shared with slow-aging mice (Morita et al.,
2011). CNOT6 and CNOT6L were tested because they may regulate DNA
repair (Sanchez-Perez et al., 2009). As shown in Fig. 4, CNOT1 and
CNOT3 levels are lower, and CNOT6 and CNOT6L higher, in liver from
each variety of slow-aging mice.
CNOT1 and CNOT3 mRNA CT values are higher in Snell and GHRKO
liver (Fig. 4) in good agreement with the protein data. In contrast, we
found no changes in the CNOT6 mRNA levels with respect to WT
controls and, unexpectedly, found a significant reduction in CNOT6L
mRNA (Fig. 4A,B). The results of CNOT6 and CNOT6L do not correspond
with the level of their protein expression. We do not know the reason for
this discrepancy but it suggests that CNOT components may also
themselves be subject to post-transcriptional regulation. CNOT4, which
does not associate with CCR4-NOT in mammals and does not regulate
mRNA stability or translation (Shirai et al., 2014), did not differ between
long-lived and littermate control mice (Fig. S2, Supporting information).
Feeding mice increases CNOT3 expression (Morita et al., 2011).
Interesting, provision of food after a period of fasting increased CNOT3
and CNOT6LmRNA expression in control mice, but not in Snell littermates
(Fig. 4D). These results could be explained by a higher level of mTORC1
activity in control mice (WT) that could contribute to the differential
upregulation of CNOT3 and CNOT6L mRNA in response to food.
Rapamycin inhibition of mTORC1 activity mimics some of the
changes in the CCR4-CNOT complex expression found in
Snell, GHRKO, and PAPPA-KO mice
To test the hypothesis that mTOR can regulate the expression of
components of the CCR4-NOT complex, we treated primary mouse
Fig. 3 Rapamycin enhances MGMT and
NDRG1 protein expression but does not
significantly alter their mRNA expression.
(A) Representative Western blots showing
pS6, p4E-BP1, and pAKT phosphorylation
(in parallel to total S6, 4E-BP1 and AKT
protein), as well as NDRG1 and MGMT
expression in mouse fibroblasts, either
untreated (, Control) or treated with
rapamycin (+, Rapa). Bar graphs represent
the mean  SEM from six independent
experiments normalized with respect to WT
controls. The CT value dotplots show mRNA
levels from six independent experiments.
The (*) indicates statistical significance.
(B) Analysis of rapamycin effects in liver of
UM-HET mice from at least eight mice per
group.
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fibroblasts with rapamycin and analyzed the expression of CNOT1,
CNOT3, CNOT6, and CNOT6L using Western blots and qRT–PCR.
Rapamycin significantly decreased CNOT1 and CNOT3 protein expres-
sion and enhanced expression of CNOT6L; however, CNOT6 protein was
not affected (Fig. 5A). Rapamycin significantly diminished CNOT1,
CNOT3, and CNOT6L mRNA but not CNOT6 mRNA (Fig. S3, Supporting
information). This pattern of consistent changes in protein and mRNA
data for CNOT1, CNOT3, and CNOT6L is similar to that noted for Snell,
GHRKO, and PAPPA-KO mice (Fig. 4). For in vivo confirmation, we
treated mice with rapamycin for 48 h and analyzed the expression of
CCR4-NOT components in liver. Rapamycin reduced CNOT1 and CNOT3
and enhanced CNOT6L, but did not change CNOT6 (Fig. 5B), consistent
with the fibroblast results. Thus, CNOT1, CNOT3, and CNOT6L are under
the control of mTOR signaling at the level of transcription and post-
transcriptional mechanisms. In contrast, CNOT6 is not affected by
rapamycin at the dose and time used.
CNOT3 regulates NDRG1 and MGMT protein expression
To see whether CNOT3 or CNOT6L might be involved in mTORC1
regulation of NDRG1 and MGMT protein expression, we transfected
mouse fibroblasts with constructs overexpressing human CNOT3 and
CNOT6L (GFP-CNOT3, GFP-CNOT6L). Human CNOT3 and CNOT6L share
95–99% of their amino acid sequence with their mouse homologs and
thus are likely to function in mouse cells. In addition, we tested the effects
of reduction of CNOT3 and CNOT6L expression using silencing constructs
(shRNAs) tailored to their respectivemouse genes.Mouse fibroblasts were
transfected, and efficiency was measured using green fluorescent protein
(Fig. S4A, Supporting information). Quantification showed a range from
10 to 30% efficiency, depending on the construct (data not shown).
Immunoblotting shows the expected increases or declines in CNOT3 and
CNOT6L protein at 72 h after transfection (Fig. S4B, Supporting
information). Overexpression of CNOT3 led to reduction in NDRG1 and
MGMT protein expression, while CNOT3 downregulation increased
NDRG1 and MGMT (Fig. 6A, top panel). Statistical analysis confirmed
significant effects in NDRG1 and MGMT expression by CNOT3 (Fig. 6B).
Neither overexpression nor reduction of CNOT6L protein affected NDRG1
or MGMT protein expression. Furthermore, changes in CNOT3 and
CNOT6L did not affectmTOR activity (no changes in phosphorylation of S6
or AKT(473)), suggesting that CCR4-NOT is downstream of mTOR in
regulating NDRG1 and MGMT expression (Fig. 6A). These results suggest
that CNOT3 is a post-transcriptional regulator of NDRG1 and MGMT
protein expression and that declines in CNOT3 in Snell, GHRKO, and
PAPPA-KOmicemay be involved in the enhanced expression of these DNA
repair enzymes.
Discussion
Our data showing reduction of mTORC1 in multiple tissues of Snell,
GHRKO (Dominick et al., 2015), and now PAPPA-KO mice support the
Fig. 4 Livers of Snell mice (DW), GHRKO,
and PAPPA-KO (KO) mice show declines in
CNOT1 and CNOT3 accompanied by
increases in CNOT6L and CNOT6 protein.
(A) Left panels represent Western blots of
CCR4-CNOT complex components in Snell
mice (DW) and control mice (WT) from liver.
Quantification shown as mean  SEM of
three experiments in middle panels from a
total of 12 mice (six females and six males)
per group using normalization as described
in Fig. 1. Right panel shows the qRT–PCR
CT values for CCR4-CNOT mRNA levels in
livers from at least 14 mice (seven females
and seven males) per group. The (*)
indicates statistical significance relative to
the WT controls of each group. (B) Data for
protein levels in GHRKO mice (left and
middle panels), using six mice (three
females and three males) per group. qRT–
PCR CT data (right panels) from at least 12
mice (six females and six males) per group.
(C) Data for protein in PAPPA-KO (KO)
mice, using nine mice (five females and four
males) per group. (D) Effect of fasting and
feeding on mRNA expression of CNOT3 and
CNOT6L in livers of Snell (DW) and WT
control mice from at least six mice (1/2
females and 1/2 males) per group. The (*)
indicates statistical significance relative to
Snell (DW).
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hypothesis that mTORC1 controls some of the intracellular events
leading to lifespan extension in mammals. It is still unclear, however,
how lower mTORC1 action might lead to improved health and better
survival in aging mice. Many lines of evidence (Lombard & Miller, 2012)
suggest that increases in stress resistance (Murakami, 2006), including
better DNA repair (De Luca et al., 2013), may be involved in longevity
and disease resistance. This idea is now supported by our observation
of increases in MGMT and NDRG1, which are involved in direct reversal
of DNA damage, in multiple tissues of three stocks of slow-aging mice.
Our evidence that reducing mTORC1 activity leads to enhancement in
MGMT and NDRG1 protein expression, both in cultured cells and in
mice, strongly suggests a link between mTOR signaling and the DNA
repair pathway (Strozyk & Kulms, 2013) that may be central in delaying
the aging process. Our data also suggest a possible involvement of
mTORC1-mediated alteration in post-transcriptional regulation of
MGMT and NDRG1 translation via changes in elements of the CCR4-
CNOT complex.
Comparative microarray analysis among several genetic models
(Svensson et al., 2011; Hofmann et al., 2015), pharmacological inter-
ventions (Miller et al., 2014; Yu et al., 2015), and dietary interventions
(Bartke et al., 2007) known to extend lifespan has not revealed
consistent shared features at the level of transcriptional changes,
including mRNA levels for enzymes from the DNA repair response such
as MGMT and NDRG1. These observations are consistent with our qRT–
PCR analysis, which showed no significant changes in NDRG1 and
MGMT mRNA expression in the Snell, GHRKO, and PAPPA-KO mice with
respect to controls (Fig. 2). The discrepancy between the mRNA and
protein levels suggested that a post-transcriptional mechanism may be
involved in the physiology of these mouse models and in the control of
longevity and age-dependent diseases.
Our data suggest that the CCR4-NOT complex, a key regulator of
post-transcriptional gene expression, may link mTOR changes to DNA
repair in these slow-aging mice. Snell, GHRKO, and PAPPA-KO mice
show a consistent pattern of changes in CNOT1, CNOT3, CNOT6, and
CNOT6L, both in cultured cells and in intact mice, a pattern recapitulated
in control cells and in control mice by short-term exposure to rapamycin.
Thus, regulation of key CCR4-NOT expression components seems to be
under the control of mTORC1 (such as CNOT1, CNOT3 and CNOT6L
shown in Fig. 5), and down regulation of CNOT3 expression seems to
upregulate NDRG1 and MGMT protein expression (Fig. 6). The CCR4-
NOT complex has been studied in yeast (Shirai et al., 2014), but little is
known about the function of individual components in higher organisms
such as mice (Shirai et al., 2014).
CCR4-NOT components, including CNOT3, CNOT6, and CNOT6L, can
regulate mRNA stability, microRNA function, localization to the P/Stress
bodies, and preferential translation (Shirai et al., 2014). However, this
regulation involves the interaction of a wide range of tissue-specific
mRNA-binding proteins (Reese, 2013; Temme et al., 2014), and thus
more multifaceted work will be needed to determine how the changes in
CNOT protein levels shown in Fig. 4 contribute to protection against
age-related changes in specific cell and tissue types. Recent studies in
Snell, GHRKO, and PAPPA-KO mice have shown a common physiology
that may control aging rate and multiple age-related diseases (Murakami
et al., 2003; Boylston et al., 2006; Brown-Borg, 2006). These mice all
exhibit high insulin sensitivity and an increased oxygen consumption with
high levels of peroxisome proliferator-associated receptor c coactivator 1
(Pgc1a) from oxidative phosphorylation (Corton & Brown-Borg, 2005;
Stauber et al., 2005). Similarly, CNOT3 heterozygous mice (Morita et al.,
2011) have been shown to have increased insulin sensitivity, oxidative
phosphorylation (including higher Pgc1a expression), and oxygen
consumption. Our data suggest that CCR4-NOT complex, including
CNOT3, could be one of the signaling pathways downstream of
Fig. 5 Rapamycin treatment decreases CNOT1 and CNOT3 expression and
increases CNOT6L protein expression, but does not affect CNOT6 expression.
(A) Representative Western blots showing expression of components of the
CCR4-CNOT complex in mouse fibroblasts untreated (, Control) or treated with
rapamycin (+, Rapa). Bar graphs represent the mean  SEM from a total of six
independent experiments normalized with respect to WT controls. The (*) indicates
statistical significance. (B) Analysis of rapamycin effects on CNOT components in
mouse livers, either untreated (, Control) or treated with rapamycin (+, Rapa)
from at least eight mice per group (50% males).
Fig. 6 Effect of overexpressing or downregulating CNOT3 and CNOT6L protein
on NDRG1 and MGMT protein expression in mouse fibroblasts. (A) Representative
Western blots for NDRG1 and MGMT expression after 72 h of transfection,
together with pS6, pAKT, CNOT1, CNOT6 in the same samples. (B) Quantification
of the NDRG1 and MGMT protein expression after each transfection shown as
mean  SEM normalized to controls for six independent experiments; the (*)
indicates statistical significance.
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mTORC1 regulating some of these changes (Fig. 2). Therefore, it would
be interesting to test if declines in CNOT3 [such as in the CNOT3
heterozygous mice (Morita et al., 2011)], along with changes in other
components of the CCR4-NOT, could themselves extend lifespan. It
would also be interesting to define what specific mechanism the CCR4-
NOT components are using to enhance expression of the MGMT and
NDRG1 DNA repair genes, such as regulation by microRNA or prefer-
ential translation (or both). Because many of the CCR4-NOT components
are essential for development, future studies of CCR4-NOT and its
effects on DNA repair and the aging process would require the use of
conditional knockouts triggered in adulthood. Of particular interest in
the aging processes would be CCR4-NOT components that affect post-
transcriptional mechanisms, such as CNOT6 and CNOT6L. Alternatively,
when available, the analysis of CNOT6 and CNOT6L +/ heterozygous
mice would also shed some light on possible functions of CNOT in aging.
On the other hand, it is also possible that changes in proteasomal
function in slow-aging mice could contribute to the elevation of MGMT,
NDRG1, and CNOT6L (Wang & Miller, 2012; Zhang et al., 2014; Zhang
& Manning, 2015).
Increases in CNOT6L have been suggested to increase the ATM-
dependent DNA repair response (Sanchez-Perez et al., 2009). In this
context, it will be interesting to determine whether tissues from slow-
aging mice have increases in other DNA repair mechanisms, or,
alternatively, whether being heterozygous for CNOT components would
lead to changes in DNA repair that may affect the aging process. Overall,
the data presented here suggest a signaling pathway in which alterations
in mTOR, including declines in mTORC1, lead to alterations in post-
transcriptional regulation of gene expression, including genes involved in
DNA repair, via changes in composition and function of the CCR4-NOT
complex.
Material and methods
Reagents, mice, and fasting and feeding conditions
Snell (DW) were produced as previously described (Dominick et al.,
2015). Breeding stock for GHRKO mice was provided by Andrzej Bartke
(Southern Illinois University, IL) and John Kopchick (Edison Biotechnology
Institute of Ohio University, OH) and mice were produced as previously
described (Dominick et al., 2015). Breeding stock for PAPPA-KO mice
was provided by Cheryl Conover (Mayo Clinic, Rochester, MN) and mice
were produced as previously described (Conover et al., 2004). DW,
GHRKO, and PAPPA-KO mice were used at ages from 5 to 6 months.
Genetically heterogeneous mice (UM-HET3) ranging from 10 to
12 months of age were produced by a cross between two different F1
parents: (BALB/cByJ 9 C57BL/6J)F1 mothers and (C3H/HeJ 9 DBA/2J)F1
fathers as previously described (Harrison et al., 2009). All experiments
were approved by the University of Michigan University Committee on
Use and Care of Animals. Sentinel animals were examined quarterly for
evidence of viral infection; all tests were negative. Mice used were fed ad
lib or, as indicated in the text, fasted for 18 h (fasted mice) followed by
ad lib feeding with a regular chow diet for 6 h (fed mice). All mice had
free access to water during the course of treatments. Chemical reagents
were purchased from Sigma (www.sigmaldrich.com). Rapamycin was
purchased from LC laboratories (www.lclabs.com). The source of
antibodies and phospho-specific antibodies are described in Table S3.
Primary mouse fibroblasts from UM-HET3 mice were cultured as
described (Murakami et al., 2003). Clones corresponding to human
CNOT3 (pT7-EGFP-HsNOT3, Addgene plasmid 37369) and CNOT6L
(pT7-EGFP-HsNOT6L, Addgene plasmid 37372) were a gift from Elisa
Izaurralde (Max Planck Institute for Developmental Biology, Germany).
The shRNA for mouse CNOT3 (NM_146176.2) and mouse CNOT6L
(NM_144910.1) were purchased from Genecopoeia (www.genecopoeia.
com). Plasmid transfections were carried out with lipofectamine 3000 as
described by the manufacturer (www.thermofisher.com). qRT–PCR was
performed as described (Li et al., 2013). Probes were manufactured by
IDT (www.idtdna.com) corresponding to the sequences shown in
Table S4.
Rapamycin treatments, tissue preparation, Western blot
analysis
Acute rapamycin treatments in UM-HET3 mouse fibroblasts were
performed at 0.1 lM. In vivo rapamycin treatments were performed
with a single intraperitoneal injection of rapamycin at 5 mg kg1 to each
UM-HET mouse (ranging from 10 to 12 months of age) as previously
described (Houde et al., 2010). Tissues from each mouse were collected,
frozen with liquid nitrogen, and stored at 70 °C. The tissue samples
were then processed to obtain cell lyses for Western blots (Dominick
et al., 2015) or qRT–PCR analysis (Li et al., 2013). Mouse fibroblasts
were collected and lysed, and equal amounts of protein were loaded for
Western blot analysis (Murakami et al., 2003).
Statistical analysis
Unless indicated otherwise, results are presented as mean  standard
error of the mean (SEM). Statistical tests for genotype, fasting and fed
conditions (nutritional), or interaction effects were assessed by two-way
analysis of variance (ANOVA) using P = 0.05 as the threshold for
significant effects. To compare specific effects between groups, an
unpaired t-test was used with P = 0.05 as the criterion for significance.
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Fig. S1 The CT dotplot graphs for GAPDH mRNA used for normalization
controls from liver samples from Snell (DW), GHRKO (B) or PAPPA (C) show
no statistically significant differences.
Fig. S2 The CT dotplot graphs for CNOT4 and GAPDH mRNA used as
normalizing controls from liver samples of Snell (A) and GHRKO (B) show no
statistically significant differences.
Fig. S3 The CT value graphs representing the CNOT mRNA levels in mouse
fibroblasts untreated (, control) or treated with Rapamycin (+, Rapa) from 6
independent experiments. The (*) indicates statistical significance.
Fig. S4 (A) Representative phase contrast and green fluorescence channels of
mouse fibroblasts overexpressing the human GFP-CNOT3 or GFP-CNOT6L, as
well as the silencing shCNOT3, shCNOT6L and respective control vectors.
Table S1 Effects of genotype and feeding on the ratio of pS6 and p4E-BP1 in
different tissues from PAPP-A (KO) mice compared to control mice (WT).
Table S2 Effects of genotype and feeding on the ratio of pNDRG1 and pAKT
(450) in different tissues from PAPP-A (KO) mice compared to control mice
(WT).
Table S3 Source of antibodies.
Table S4 qRT-PCR probes.
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